Status:
COMPLETED
N-acetyl Cysteine for Ovulation Induction in Clomiphene Citrate Resistant Polycystic Ovary Syndrome
Lead Sponsor:
Assiut University
Conditions:
Polycystic Ovary Syndrome
Eligibility:
FEMALE
18-39 years
Phase:
PHASE4
Brief Summary
Polycystic ovary syndrome is a major endocrinological disorder affecting 5-8% of reproductive aged women. Anovulation is a major feature of the syndrome, managed primarily by clomiphene citrate. Failu...
Detailed Description
Resistance to ovulation induction therapy with clomiphene citrate (CC) is a significant problem affecting as many as 25% of patients. Laparoscopic ovarian drilling is an accepted second line treatment...
Eligibility Criteria
Inclusion
- PCOS patients according to Rotterdam criteria who failed to respond to 6 month ovulation induction therapy with clomiphene citrate,
- normal semen analysis of partner
- normal tubo-peritoneal anatomy as assessed by laparoscopy
Exclusion
- patients who have other causes of infertility
- patients receiving gonadotrophin ovulation induction
Key Trial Info
Start Date :
January 1 2012
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
January 1 2014
Estimated Enrollment :
70 Patients enrolled
Trial Details
Trial ID
NCT02239107
Start Date
January 1 2012
End Date
January 1 2014
Last Update
September 12 2014
Active Locations (0)
Enter a location and click search to find clinical trials sorted by distance.
No Results Found
We couldn’t find results for the location/zipcode entered or within the selected range. Please check your input or adjust your search.